Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomerica has demonstrated statistically significant clinical results for its inFoods® IBS test. In a multi-center study at leading institutions including Mayo Clinic and Harvard-affiliated hospitals, the test showed a clinically meaningful improvement in abdominal pain intensity responder rates (>30%) compared to placebo diet arms (p=0.0246), with efficacy similar to or better than current drugs on the market. The company also markets over 80 advanced diagnostic products globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomerica.